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Molecular characterisation of FFPE pancreatic tumours treated with 5-Fluorouracil 
(5-FU) and Sonodynamic Therapy (SDT) using whole transcriptome analysis 
Introduction 
 
•Current standards of care in 
pancreatic cancer (PC), such as 
surgical resection and 
chemoradiotherapy, remain 
ineffective in improving overall 
survival rates in PC 
•Sonodynamic therapy (SDT) is a 
novel treatment modality that 
utilises ultrasound in conjunction 
with sonosensitisers to destroy 
tumors in a site-specific manner1 
•This study aimed to investigate 
the effect of 5-Fluorouracil (5-FU) 
and SDT on expression levels of 
genes involved in aberrant 
signaling in PC using Next 
Generation Sequencing 
technology such as the Ion 
Proton™ System  
 
 
•Bioinformatics analysis was 
performed using R/bioconductor 
and Database for Annotation, 
Visualization and Integrated 
Discovery (DAVID)  
 
Discussion 
 
•BCL3 expression was lower in 
both SDT and 5-FU treated 
samples as compared to 
untreated control sample, 
suggesting both treatment 
modalities cause lower BCL3 
expression levels 
•Functional clustering revealed 
the involvement of G-Protein 
coupled receptors (GPCR) and 
signal transduction pathways in 
PC 
•Bioinformatics analysis also 
revealed two genes that showed 
the highest levels of differential 
expression between treated and 
untreated samples: 
 
•ATP1B1 had 8.94 times lower 
expression levels in 5-FU 
sample compared to control, 
and this plays an integral role in 
the membrane protein Na+/K+-
ATPase involved in energy 
production3 
•RUNDC1 had 6.99 times 
higher expression levels in SDT 
sample compared to control, 
and this is associated with a 
transcription factor that is 
involved with ubiquitination4 
 
•Further work will validate the 
presence of ATP1B1 and 
RUNDC1 using qRT-PCR, by 
performing in vitro studies on 
untreated and treated cell lines 
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Materials & Methods 
 
 
 
•RNA extraction was performed on 
3 FFPE specimens of BxPC-3 
human pancreatic adenocarcinoma 
cells in a mouse model that were 
subjected to the following 
treatments2: 
 
1.Untreated (Control) 
2.440uM 5-FU  
3.O2MB-RB* and 440uM 5-FU  
treated with ultrasound (SDT) 
 
•Sample validation was performed 
using qRT-PCR, qPCR and a 
bioanalyser 
•Whole transcriptome amplification 
was performed using an Ion 
AmpliSeq™ RNA Library Kit Whole 
transcriptome sequencing was 
performed using the Ion Proton™ 
System on amplified transcriptomes 
 
* Oxygen-carrying microbubbles with 
covalently attached rose bengal on 
their surface 
 
 
Results 
Figure 1. Mean E-ΔCT of three samples. 
E-ΔCT was calculated by taking 2-(CT gene of 
interest – CT reference gene) for each sample. 
Error bars represent standard error of 
 the mean where n = 3 
Figure 2. Unsupervised hierarchical 
clustering was applied to normalised 
 RNA-seq values using R/Bioconductor. 
 A heatmap representation of 
 differentially expressed genes among 
 all samples was generated  
•Statistically significant differences 
in BCL3 expression levels between 
SDT and control (p = 0.001) and 5-
FU and control (p = 0.001) were 
observed (Figure 1.) 
•Clustering's heatmap shows 
different transcriptomic signatures 
between three transcripts 
suggesting that each treatment 
targets different transcriptomic 
signature (Figure 2.) 
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